預計陣列儀器市場將在 2025 年至 2032 年預測期內成長。許多慢性疾病（尤其是癌症）的診斷和預後的需求增加是推動市場發展的主要因素。世界各地各種疾病的發病率不斷上升，查明其病因並隨後確定治療方案的需求也日益增長，這推動了市場擴張。
Frequently Asked Questions
The market is segmented based on Segmentation, By Technology (DNA Microarrays, Protein Microarrays, Cellular Microarrays, Tissue Microarrays), End User (Research and Development Laboratories, Clinical Diagnostic Labs, Agriculture Research Centers, Veterinary Laboratories, Forensic Centers) – Industry Trends and Forecast to 2032
.
The Global Array Instruments Market size was valued at USD 1.30 USD Billion in 2024.
The Global Array Instruments Market is projected to grow at a CAGR of 5.8% during the forecast period of 2025 to 2032.
The major players operating in the market include Thermo Fisher Scientific Inc. AGilent TechnologiesInc. , IlluminaInc. , Arrayit Corporation , Laboratory Corporation of America Holdings , OriGene TechnologiesInc. , Oxford Gene Technology IP Limited, Pepscan , PerkinElmer Inc. , Phalanx Biotech Group , QIAGEN , RayBiotech Life Inc. , Retrogenix , Luminex Corporation , MESO SCALE DIAGNOSTICSLLC .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
